These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 16625586

  • 21. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Knight JF, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD001533. PubMed ID: 15674881
    [Abstract] [Full Text] [Related]

  • 22. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004293. PubMed ID: 15495098
    [Abstract] [Full Text] [Related]

  • 23. Interventions for preventing and treating kidney disease in IgA vasculitis.
    Hahn D, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2023 Feb 28; 2(2):CD005128. PubMed ID: 36853224
    [Abstract] [Full Text] [Related]

  • 24. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
    Chen Y, Gong Z, Chen X, Tang L, Zhao X, Yuan Q, Cai G.
    Cochrane Database Syst Rev; 2013 Aug 11; (8):CD008568. PubMed ID: 23934958
    [Abstract] [Full Text] [Related]

  • 25. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Aug 07; 2015(8):CD005128. PubMed ID: 26258874
    [Abstract] [Full Text] [Related]

  • 26. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD001533. PubMed ID: 17943754
    [Abstract] [Full Text] [Related]

  • 27. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.
    Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS.
    Health Technol Assess; 2007 Oct 17; 11(21):iii-iv, ix-xi, 1-93. PubMed ID: 17537341
    [Abstract] [Full Text] [Related]

  • 28. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2015 Aug 03; (8):CD003965. PubMed ID: 26235292
    [Abstract] [Full Text] [Related]

  • 29. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Mar 18; 2015(3):CD001533. PubMed ID: 25785660
    [Abstract] [Full Text] [Related]

  • 30. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults.
    Braun N, Schmutzler F, Lange C, Perna A, Remuzzi G, Risler T, Willis NS.
    Cochrane Database Syst Rev; 2008 Jul 16; 2008(3):CD003233. PubMed ID: 18646090
    [Abstract] [Full Text] [Related]

  • 31. Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials.
    Durkan AM, Hodson EM, Willis NS, Craig JC.
    Kidney Int; 2001 May 16; 59(5):1919-27. PubMed ID: 11318964
    [Abstract] [Full Text] [Related]

  • 32. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 33. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Townsend CM, Parker CE, MacDonald JK.
    Cochrane Database Syst Rev; 2016 Oct 26; 10(10):CD000545. PubMed ID: 27783843
    [Abstract] [Full Text] [Related]

  • 34. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Tsoulis DJ, MacDonald JK.
    Cochrane Database Syst Rev; 2013 Apr 30; (4):CD000545. PubMed ID: 23633304
    [Abstract] [Full Text] [Related]

  • 35. Treatment for lupus nephritis.
    Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD002922. PubMed ID: 23235592
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials].
    Chen LZ, Jiang XY, Lu HY, Zhang QL, Mo Y.
    Zhonghua Er Ke Za Zhi; 2009 Dec 12; 47(12):898-903. PubMed ID: 20193140
    [Abstract] [Full Text] [Related]

  • 37. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Chartapisak W, Opastirakul S, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD005128. PubMed ID: 19588365
    [Abstract] [Full Text] [Related]

  • 38. Immunosuppressive agents for treating IgA nephropathy.
    Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA.
    Cochrane Database Syst Rev; 2003 Jul 08; (4):CD003965. PubMed ID: 14584001
    [Abstract] [Full Text] [Related]

  • 39. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 40. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
    Feng M, Yuan W, Zhang R, Fu P, Wu T.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD006335. PubMed ID: 23740567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.